Wells Fargo’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.57B | Buy |
4,646,119
+240,275
| +5% | +$245M | 0.9% | 17 |
|
|
2026
Q1 | $4.05B | Buy |
4,405,844
+73,189
| +2% | +$74.2M | 0.76% | 19 |
|
|
2025
Q4 | $4.66B | Buy |
4,332,655
+1,109,230
| +34% | +$1.06B | 0.85% | 17 |
|
|
2025
Q3 | $2.46B | Buy |
3,223,425
+104,108
| +3% | +$77.5M | 0.47% | 38 |
|
|
2025
Q2 | $2.43B | Buy |
3,119,317
+153,508
| +5% | +$119M | 0.5% | 35 |
|
|
2025
Q1 | $2.45B | Buy |
2,965,809
+9,106
| +0.3% | +$7.58M | 0.56% | 32 |
|
|
2024
Q4 | $2.28B | Buy |
2,956,703
+13,154
| +0.4% | +$10.9M | 0.51% | 38 |
|
|
2024
Q3 | $2.61B | Sell |
2,943,549
-23,992
| -0.8% | -$21.6M | 0.59% | 32 |
|
|
2024
Q2 | $2.69B | Buy |
2,967,541
+46,841
| +2% | +$37.5M | 0.65% | 29 |
|
|
2024
Q1 | $2.27B | Sell |
2,920,700
-127,130
| -4% | -$90.5M | 0.55% | 38 |
|
|
2023
Q4 | $1.78B | Buy |
3,047,830
+132,699
| +5% | +$77.5M | 0.46% | 51 |
|
|
2023
Q3 | $1.57B | Sell |
2,915,131
-137,918
| -5% | -$71.1M | 0.46% | 52 |
|
|
2023
Q2 | $1.43B | Buy |
3,053,049
+52,574
| +2% | +$22M | 0.4% | 64 |
|
|
2023
Q1 | $1.03B | Sell |
3,000,475
-19,016
| -0.6% | -$6.41M | 0.3% | 81 |
|
|
2022
Q4 | $1.1B | Sell |
3,019,491
-10,227
| -0.3% | -$3.63M | 0.33% | 74 |
|
|
2022
Q3 | $980M | Sell |
3,029,718
-168,172
| -5% | -$53.3M | 0.32% | 75 |
|
|
2022
Q2 | $1.04B | Sell |
3,197,890
-61,248
| -2% | -$18.4M | 0.32% | 78 |
|
|
2022
Q1 | $933M | Buy |
3,259,138
+121,649
| +4% | +$31.3M | 0.24% | 99 |
|
|
2021
Q4 | $867M | Sell |
3,137,489
-141,319
| -4% | -$35.8M | 0.22% | 110 |
|
|
2021
Q3 | $758M | Sell |
3,278,808
-108,148
| -3% | -$26.7M | 0.17% | 126 |
|
|
2021
Q2 | $777M | Sell |
3,386,956
-458,312
| -12% | -$92.1M | 0.17% | 126 |
|
|
2021
Q1 | $718M | Sell |
3,845,268
-527,946
| -12% | -$103M | 0.16% | 134 |
|
|
2020
Q4 | $738M | Sell |
4,373,214
-199,710
| -4% | -$29.8M | 0.18% | 126 |
|
|
2020
Q3 | $677M | Buy |
4,572,924
+172,577
| +4% | +$26.7M | 0.19% | 121 |
|
|
2020
Q2 | $722M | Buy |
4,400,347
+489,799
| +13% | +$75.2M | 0.21% | 106 |
|
|
2020
Q1 | $542M | Sell |
3,910,548
-345,756
| -8% | -$47.5M | 0.19% | 120 |
|
|
2019
Q4 | $559M | Sell |
4,256,304
-306,311
| -7% | -$35.5M | 0.15% | 142 |
|
|
2019
Q3 | $510M | Sell |
4,562,615
-5,783
| -0.1% | -$644K | 0.14% | 146 |
|
|
2019
Q2 | $506M | Sell |
4,568,398
-260,033
| -5% | -$30.6M | 0.14% | 148 |
|
|
2019
Q1 | $627M | Sell |
4,828,431
-586,027
| -11% | -$71.3M | 0.19% | 124 |
|
|
2018
Q4 | $627M | Buy |
5,414,458
+452,936
| +9% | +$50.6M | 0.21% | 108 |
|
|
2018
Q3 | $532M | Sell |
4,961,522
-11,726
| -0.2% | -$1.17M | 0.15% | 140 |
|
|
2018
Q2 | $424M | Sell |
4,973,248
-535,936
| -10% | -$44M | 0.13% | 158 |
|
|
2018
Q1 | $426M | Buy |
5,509,184
+350,518
| +7% | +$28.2M | 0.13% | 161 |
|
|
2017
Q4 | $436M | Buy |
5,158,666
+161,657
| +3% | +$13.8M | 0.13% | 164 |
|
|
2017
Q3 | $427M | Sell |
4,997,009
-297,506
| -6% | -$24.4M | 0.13% | 163 |
|
|
2017
Q2 | $436M | Buy |
5,294,515
+507,408
| +11% | +$41.4M | 0.14% | 162 |
|
|
2017
Q1 | $403M | Sell |
4,787,107
-351,961
| -7% | -$28.2M | 0.13% | 164 |
|
|
2016
Q4 | $378M | Buy |
5,139,068
+1,375,943
| +37% | +$102M | 0.13% | 162 |
|
|
2016
Q3 | $302M | Buy |
3,763,125
+1,983,356
| +111% | +$159M | 0.11% | 202 |
|
|
2016
Q2 | $140M | Sell |
1,779,769
-287,729
| -14% | -$21.7M | 0.05% | 380 |
|
|
2016
Q1 | $149M | Sell |
2,067,498
-35,193
| -2% | -$2.66M | 0.06% | 353 |
|
|
2015
Q4 | $177M | Buy |
2,102,691
+41,735
| +2% | +$3.46M | 0.07% | 307 |
|
|
2015
Q3 | $172M | Sell |
2,060,956
-650,228
| -24% | -$54.9M | 0.07% | 310 |
|
|
2015
Q2 | $226M | Sell |
2,711,184
-23,297
| -0.9% | -$1.78M | 0.09% | 260 |
|
|
2015
Q1 | $199M | Sell |
2,734,481
-171,094
| -6% | -$12.2M | 0.08% | 291 |
|
|
2014
Q4 | $200M | Buy |
2,905,575
+149,704
| +5% | +$10.1M | 0.08% | 291 |
|
|
2014
Q3 | $179M | Buy |
2,755,871
+105,035
| +4% | +$6.65M | 0.07% | 304 |
|
|
2014
Q2 | $165M | Buy |
2,650,836
+132,816
| +5% | +$7.92M | 0.07% | 336 |
|
|
2014
Q1 | $148M | Sell |
2,518,020
-211,673
| -8% | -$11.8M | 0.06% | 353 |
|
|
2013
Q4 | $139M | Sell |
2,729,693
-173,353
| -6% | -$8.68M | 0.06% | 355 |
|
|
2013
Q3 | $146M | Sell |
2,903,046
-49,010
| -2% | -$2.57M | 0.07% | 320 |
|
|
2013
Q2 | $145M | Buy |
+2,952,056
| New | +$161M | 0.08% | 312 |
|
Other funds holding LLY
Wells Fargo's LLY Position: Q2 2026 in Review
Wells Fargo increased its Eli Lilly (LLY) stake by 5.5% in Q2 2026, buying an estimated $245M and bringing the position to 4,646,119 shares worth $5.57B. The position accounts for 0.9% of the portfolio, ranked #17.
Wells Fargo first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wells Fargo held 4,646,119 shares of Eli Lilly worth $5.57B as of Q2 2026.
- Wells Fargo bought 240,275 Eli Lilly shares in Q2 2026, an estimated $245M.
- Eli Lilly made up 0.9% of Wells Fargo's portfolio in Q2 2026, its #17 holding.
- Wells Fargo first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.